Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.30
-4.86%
Mkt Cap $717.71M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$3.70
Range $3.70 – $3.70
Implied Upside
-14.0%
Consensus $3.70 vs current $4.30